Style | Citing Format |
---|---|
MLA | Baghdadi H, et al.. "Combination of Minimal Residual Disease on Day 15 and Copy Number Alterations Results in Bcr-Abl1-Negative Pediatric B-All: A Powerful Tool for Prediction of Induction Failure." Cancer Genetics, vol. 282-283, no. , 2024, pp. 27-34. |
APA | Baghdadi H, Soleimani M, Zavvar M, Bahoush G, Poopak B (2024). Combination of Minimal Residual Disease on Day 15 and Copy Number Alterations Results in Bcr-Abl1-Negative Pediatric B-All: A Powerful Tool for Prediction of Induction Failure. Cancer Genetics, 282-283(), 27-34. |
Chicago | Baghdadi H, Soleimani M, Zavvar M, Bahoush G, Poopak B. "Combination of Minimal Residual Disease on Day 15 and Copy Number Alterations Results in Bcr-Abl1-Negative Pediatric B-All: A Powerful Tool for Prediction of Induction Failure." Cancer Genetics 282-283, no. (2024): 27-34. |
Harvard | Baghdadi H et al. (2024) 'Combination of Minimal Residual Disease on Day 15 and Copy Number Alterations Results in Bcr-Abl1-Negative Pediatric B-All: A Powerful Tool for Prediction of Induction Failure', Cancer Genetics, 282-283(), pp. 27-34. |
Vancouver | Baghdadi H, Soleimani M, Zavvar M, Bahoush G, Poopak B. Combination of Minimal Residual Disease on Day 15 and Copy Number Alterations Results in Bcr-Abl1-Negative Pediatric B-All: A Powerful Tool for Prediction of Induction Failure. Cancer Genetics. 2024;282-283():27-34. |
BibTex | @article{ author = {Baghdadi H and Soleimani M and Zavvar M and Bahoush G and Poopak B}, title = {Combination of Minimal Residual Disease on Day 15 and Copy Number Alterations Results in Bcr-Abl1-Negative Pediatric B-All: A Powerful Tool for Prediction of Induction Failure}, journal = {Cancer Genetics}, volume = {282-283}, number = {}, pages = {27-34}, year = {2024} } |
RIS | TY - JOUR AU - Baghdadi H AU - Soleimani M AU - Zavvar M AU - Bahoush G AU - Poopak B TI - Combination of Minimal Residual Disease on Day 15 and Copy Number Alterations Results in Bcr-Abl1-Negative Pediatric B-All: A Powerful Tool for Prediction of Induction Failure JO - Cancer Genetics VL - 282-283 IS - SP - 27 EP - 34 PY - 2024 ER - |